(Q46172822)

20 December 2017

title

Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (English)

1 reference

20 December 2017

main subject

Klebsiella pneumoniae

0 references

author name string

Elizabeth B Hirsch

1

1 reference

20 December 2017

Beining Guo

2

1 reference

20 December 2017

Kai-Tai Chang

3

1 reference

20 December 2017

Henry Cao

4

1 reference

20 December 2017

Kimberly R Ledesma

5

1 reference

20 December 2017

Manisha Singh

6

1 reference

20 December 2017

Vincent H Tam

7

1 reference

20 December 2017

language of work or name

English

0 references

publication date

13 December 2012

1 reference

20 December 2017

Journal of Infectious Diseases

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 December 2017

volume

207

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

786-793

1 reference

20 December 2017

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Emergence of KPC-producing Klebsiella pneumoniae in Texas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase- producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Reproducibility of the microdilution checkerboard method for antibiotic synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS766

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIS766

1 reference

20 December 2017

1 reference

20 December 2017